Twan Lammers obtained a D.Sc. in Radiation Oncology from Heidelberg University in 2008 and a Ph.D. in Pharmaceutics from Utrecht University in 2009. In the same year, he started the Nanomedicine and Theranostics group at RWTH Aachen University. In 2014, he was promoted to professor of medicine at RWTH Aachen University Clinic. His group aims to individualize and improve disease treatment by combining drug targeting with imaging. To this end, image-guided (theranostic) drug delivery systems are being developed, as well as materials and methods to monitor tumor growth, angiogenesis, inflammation, fibrosis and metastasis. He received multiple scholarships and awards, including ERC starting and consolidator grants, the CRS Young Investigator Award, the Belgian Society for Pharmaceutical Science International Award and the JNB trailblazer award. He serves on the editorial board of 10 journals, and is associate editor for JCR, DDTR and MIB. He has been included in the Clarivate Analytics list of Highly Cited Researchers since 2019.